查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生殖遺傳學市場-全球行業規模、份額、趨勢、機會、預測，2018-2028 年，按成分、技術、程序類型、應用、地區、競爭
市場調查報告書
商品編碼
1255249

生殖遺傳學市場-全球行業規模、份額、趨勢、機會、預測，2018-2028 年，按成分、技術、程序類型、應用、地區、競爭

Reproductive Genetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Component, By Technology, By Procedure Type, By Application, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球生殖遺傳學市場在預測期內將出現顯著增長。

在此背景下，發展中國家對基因工程的認識提高，獲得更好的醫療服務成為可能。 此外，隨著醫療檢測報銷的改善以及政府機構為開發新的診斷中心進行的多項投資，世界不同地區對生殖遺傳學的需求顯著增加。 此外，高級檢測的顯著增加以及各年齡段女性對安全生活的意識不斷增強，也將進一步增加對生殖遺傳學的需求，並推動市場增長到 2027 年。預計 此外，人們對計劃生育的興趣增加、有利的政府法規以及各種測試的進步預計將進□□一步增加對生殖遺傳學的需求並支持市場的增長。 同樣，基因技術的進步和該技術在臨床醫學中的採用將促進其在遺傳病檢測、攜帶者篩查和不孕症鑑定方面的應用，預計在預測期內進一步推動市場增長。

對基因檢測的需求不斷增長

對懷孕期間產生的胚胎進行基因檢測和針對可能的遺傳疾病進行體外受精的需求不斷增長，這正在推動生殖遺傳學市場的增長。 通過體外受精技術對胚胎進行基因檢測的市場發展和基因檢測的一些發展使人工生殖中的遺傳疾病檢測成為可能，從而推動了預測期內的市場增長。 生殖遺傳學可以幫助識別胚胎中的缺陷，這樣父母就可以採用體外受精等替代程序來增加健康的懷孕和嬰兒，而不管患者的健康狀況如何，預計這將在預測期內持續下去。這將進一步推動市場。 根據 Statista 的數據，截至 2019 年，紐約是美國合法墮胎數量最多的州，同年報告的墮胎超過 78,000 起。 佛羅裡達州也報告了超過 71,000 起墮胎，其次是德克薩斯州，超過 57,000 起。 2019年美國共有63萬例合法墮胎。

推進基因組技術

基因組技術的進步及其在臨床醫學中的應用，以及在遺傳病診斷、攜帶者篩查、不孕原因鑑定等方面的應用，正在推動預測期內的市場增長。 然而，有些測試非常昂貴，以至於不鼓勵夫婦進行這些測試。 然而，人口測序成本的下降和混血兒人口的激增預計將增加選擇新程序的夫婦和個人，這有望在預測期內推動市場增長。 出生缺陷影響美國每年出生的 33 個嬰兒中的 1 個（約佔所有活產嬰兒的 3%）。

近期發展

  • 2021 年 5 月 Juno Diagnostics 是一家專注於改善遺傳健康信息獲取途徑的公司，宣布了由 Perceptive Xontogeny Venture (PXV) Fund 領投的 2500 萬美元 A 輪融資。宣布它是完全的。 這筆資金將支持產品開發、臨床驗證研究以及 JunoDx 無創產前檢測的商業發布。
  • 2020 年 3 月 Agilent宣布推出三款用於產前和產後研究的新型微陣列芯片。 該微陣列包含來自權威數據庫的最新臨床相關內容。 新一代測序技術的進步發現了新的基因-疾病關聯，並且數據庫正在迅速發展以包含這些發現。

自定義

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢

第 4 章 VOC（客戶之聲）

第五章全球生殖遺傳學市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按組件（實驗室診斷、試劑盒和化驗、試劑和消耗品）
    • 按技術（新一代測序、聚合□鍊式反應、原位雜交、微陣列）
    • 按程序類型（攜帶者篩查、產前篩查、植入前基因檢測、不育基因檢測）
    • 按應用（非整倍體、單基因畸變、結構染色體畸變、其他）
    • 按地區
    • 按公司分類（2022 年）
  • 市場地圖
    • 按組件
    • 按技術
    • 按程序類型
    • 通過申請
    • 按地區

第6章北美生殖遺傳學市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按組件
    • 按技術
    • 按程序類型
    • 通過申請
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 加拿大
    • 墨西哥

第七章歐洲生殖遺傳學市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按組件
    • 按技術
    • 按程序類型
    • 通過申請
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第八章亞太地區生殖遺傳學市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按組件
    • 按技術
    • 按程序類型
    • 通過申請
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第9章南美生殖遺傳學市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按組件
    • 按技術
    • 按程序類型
    • 通過申請
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東和非洲生殖遺傳學市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按組件
    • 按技術
    • 按程序類型
    • 通過申請
    • 按國家
  • MEA：國家分析
    • 南非
    • 沙特阿拉伯
    • 阿聯酋
    • 土耳其人
    • 埃及

第 11 章市場動態

  • 司機
  • 任務

第12章市場趨勢與發展

  • 近期趨勢
  • 併購
  • 產品發布

第13章競爭格局

  • 業務概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT 分析
    • CooperSurgical, Inc.
    • Centogene AG
    • Invitae Corporation
    • Illumina, Inc.
    • Myriad Genetics, Inc.,
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics
    • Natera, Inc
    • Eurofins Scientific SE

第 14 章戰略建議

簡介目錄
Product Code: 14339

The global reproductive genetics market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing awareness of genetic engineering in developing countries to get better. Additionally, growing reimbursement improvements for medical tests and initiatives, running parallel to multiple investments by government organizations for developing new diagnostic centers, have significantly increased the demand for reproductive genetics across different parts of the globe. Additionally, significant growth in advanced testing, along with increasing awareness among different age groups of women for a leading safe life, is further expected to increase the demand for reproductive genetics, thereby fuelling the market growth through 2027. Furthermore, increasing focus on family planning, favorable regulations by the government, and advancements in different testing are further expected to increase the demand for reproductive genetics, thereby supporting market growth. Similarly, advancement in geno9mic technologies and implementation of this technology in clinical medicine will enhance the usage in genetic disorder testing, carrier screening, and identification of infertility which will further boost the growth of the market during the forecast period.

Increasing demand for Genetic Testing

Increasing demand for genetic testing of embryos, either during pregnancy or of those created through IVF to check for possible genetic disorders, is driving the growth of the reproductive genetics market. Increasing genetic testing for embryos through IVF technology and several developments in genetic testing are making it possible to test for genetic disorders in artificial reproduction, which is driving the market growth during the forecast period. Reproductive genetics help to identify embryo defects so that parents can adopt alternative procedures like IVF, thus increasing the healthy pregnancy and baby regardless of patient health, which will further boost the market during the forecast period. According to Statista, as of 2019, the leading state by the number of legal abortions in the United States was New York, which reported over 78 thousand abortions that year. Florida also reported over 71 thousand abortions, followed by Texas with over 57 thousand. There was a total of 630000 legal abortions in the United States in 2019.

Growing Advancement in Genomic Technologies

Increasing advancement in genomic technologies and further implementation of these technologies in clinical medicine have enhanced their usage in the diagnosis of genetic disorders, carrier screening, and identification of the cause of infertility, propelling the market growth in the forecast period. Some tests are much more expensive, which helps couples from going ahead with the tests. However, with the decline in the cost of sequencing and the surge in the mixed-ethnicity population, an increasing number of couples/individuals are expected to opt for the new procedure, which is expected to drive the market growth during the forecast period. Birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year.

Market Segmentation

The global reproductive genetics market can be segmented by component, technology, procedure type, application, and by region. Based on components, the market can be segmented into Laboratory Developed Tests, Kits & Assays, and Reagents & Consumables. Based on technology, the market can be segmented into Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, and Microarrays. Based on procedure type, the market can be differentiated into Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, and Infertility Genetic Testing. Based on application, the market can be grouped into Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global reproductive genetics market on account of the increasing demand for genetic testing to identify genetic abnormalities in the country.

Recent Developments

  • In May 2021, Juno Diagnostics, Which is a company focusing on enhancing access to genetic health information, announced the closing of a Series A financing round for USD 25 million led by Perceptive Xontogeny Venture (PXV) Fund. The fund will support product development, clinical validation studies, and the commercial launch of JunoDx's product offerings for non-invasive prenatal testing.
  • In March 2020, Agilent Technologies announced the launch of three new microarrays for prenatal and postnatal research. The microarray includes updated clinically relevant content from respected databases. Progression of next-generation sequencing is uncovering new gene-disease associations, and databases are rapidly evolving to include these discoveries.

Market Players

CooperSurgical, Inc., Centogene AG, Invitae Corporation, Illumina, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Natera, Inc, Eurofins Scientific SE are some of the leading players operating in the Global Reproductive Genetics Market.

Report Scope

In this report, global reproductive genetics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Reproductive Genetics Market, By Component:

  • Laboratory-Developed Tests
  • Kits & Assays
  • Reagents & Consumables

Reproductive Genetics Market, By Technology:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • In Situ Hybridization, Microarrays

Reproductive Genetics Market, By Procedure Type:

  • Carrier Screening
  • Prenatal Screening
  • Preimplantation Genetic Testing
  • Infertility Genetic Testing

Reproductive Genetics Market, By Application:

  • Aneuploidy
  • Single Gene Disorder
  • Structural Chromosomal Abnormality
  • Others

Reproductive Genetics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Reproductive Genetics Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reproductive Genetics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables)
    • 5.2.2. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays)
    • 5.2.3. By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing)
    • 5.2.4. By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Component
    • 5.3.2. By Technology
    • 5.3.3. By Procedure Type
    • 5.3.4. By Application
    • 5.3.5. By Region

6. North America Reproductive Genetics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Technology
    • 6.2.3. By Procedure Type
    • 6.2.4. By Application
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Reproductive Genetics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Procedure Type
        • 6.3.1.2.4. By Application
    • 6.3.2. Canada Reproductive Genetics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Procedure Type
        • 6.3.2.2.4. By Application
    • 6.3.3. Mexico Reproductive Genetics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Procedure Type
        • 6.3.3.2.4. By Application

7. Europe Reproductive Genetics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technology
    • 7.2.3. By Procedure Type
    • 7.2.4. By Application
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Reproductive Genetics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Procedure Type
        • 7.3.1.2.4. By Application
    • 7.3.2. Germany Reproductive Genetics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Procedure Type
        • 7.3.2.2.4. By Application
    • 7.3.3. United Kingdom Reproductive Genetics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Procedure Type
        • 7.3.3.2.4. By Application
    • 7.3.4. Italy Reproductive Genetics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Procedure Type
        • 7.3.4.2.4. By Application
    • 7.3.5. Spain Reproductive Genetics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Procedure Type
        • 7.3.5.2.4. By Application

8. Asia-Pacific Reproductive Genetics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technology
    • 8.2.3. By Procedure Type
    • 8.2.4. By Application
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Reproductive Genetics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Procedure Type
        • 8.3.1.2.4. By Application
    • 8.3.2. India Reproductive Genetics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Procedure Type
        • 8.3.2.2.4. By Application
    • 8.3.3. Japan Reproductive Genetics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Procedure Type
        • 8.3.3.2.4. By Application
    • 8.3.4. South Korea Reproductive Genetics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Procedure Type
        • 8.3.4.2.4. By Application
    • 8.3.5. Australia Reproductive Genetics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Procedure Type
        • 8.3.5.2.4. By Application

9. South America Reproductive Genetics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technology
    • 9.2.3. By Procedure Type
    • 9.2.4. By Application
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Reproductive Genetics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Procedure Type
        • 9.3.1.2.4. By Application
    • 9.3.2. Argentina Reproductive Genetics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Procedure Type
        • 9.3.2.2.4. By Application
    • 9.3.3. Colombia Reproductive Genetics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Procedure Type
        • 9.3.3.2.4. By Application

10. Middle East and Africa Reproductive Genetics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technology
    • 10.2.3. By Procedure Type
    • 10.2.4. By Application
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Reproductive Genetics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Procedure Type
        • 10.3.1.2.4. By Application
    • 10.3.2. Saudi Arabia Reproductive Genetics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Procedure Type
        • 10.3.2.2.4. By Application
    • 10.3.3. UAE Reproductive Genetics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Procedure Type
        • 10.3.3.2.4. By Application
    • 10.3.4. Turkey Reproductive Genetics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Component
        • 10.3.4.2.2. By Technology
        • 10.3.4.2.3. By Procedure Type
        • 10.3.4.2.4. By Application
    • 10.3.5. Egypt Reproductive Genetics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Component
        • 10.3.5.2.2. By Technology
        • 10.3.5.2.3. By Procedure Type
        • 10.3.5.2.4. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. CooperSurgical, Inc.
    • 13.6.2. Centogene AG
    • 13.6.3. Invitae Corporation
    • 13.6.4. Illumina, Inc.
    • 13.6.5. Myriad Genetics, Inc.,
    • 13.6.6. Thermo Fisher Scientific Inc.
    • 13.6.7. Laboratory Corporation of America Holdings
    • 13.6.8. Quest Diagnostics
    • 13.6.9. Natera, Inc
    • 13.6.10. Eurofins Scientific SE

14. Strategic Recommendations